Keyphrases
Bremelanotide
100%
Conditioned Place Preference
16%
Dopamine D1 Receptor
16%
Dopamine D2 Receptor (DRD2)
16%
Dopamine Neurons
16%
Dorsal Striatum
16%
High Dose
16%
Hypoactive Sexual Desire Disorder
100%
Interneuron
16%
Mechanism of Action
16%
Melanocortin
16%
Melanocortin 1 Receptor (MC1R)
33%
Melanocortin 4 Receptor (MC4R)
50%
Mesolimbic Dopamine System
33%
Neurobiological Mechanisms
16%
Nucleus Accumbens
50%
Postmenopausal Women
16%
Receptor Expression
16%
Reward Circuit
16%
Rewarding Effect
16%
Sexual Dysfunction
16%
Sexual Experience
16%
Sexual Interaction
16%
Sexual Reward
33%
Syrian Hamster
100%
Syrian Hamster Model
16%
System Reward
16%
United States Food
16%
US FDA-approved Drugs
100%
Ventral Tegmental Area
33%
Medicine and Dentistry
Bremelanotide
100%
Conditioned Place Preference
16%
Dopamine 1 Receptor
16%
Dopamine Receptor D2
16%
Dorsal Striatum
16%
Drug Megadose
16%
Hypoactive Sexual Desire Disorder
100%
Interneuron
16%
Melanocortin
16%
Melanocortin 4 Receptor
50%
Melanocortin Receptor
33%
Messenger RNA
50%
Nucleus Accumbens
50%
Premenopause
16%
Receptor
16%
Receptor Expression
16%
Sexual Dysfunction
16%
Sexual Experience
16%
Ventral Tegmental Area
33%
Neuroscience
Bremelanotide
100%
Conditioned Place Preference
16%
Dopamine Receptor D1
16%
Dopamine Receptor D2
16%
Dorsal Striatum
16%
Hypoactive Sexual Desire Disorder
100%
Interneuron
16%
Melanocortin
16%
Melanocortin 4 Receptor
50%
Melanocortin Receptor
33%
Messenger RNA
50%
Nucleus Accumbens
50%
Receptor
16%
Receptor Expression
16%
Sexual Experience
16%
Ventral Tegmental Area
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bremelanotide
100%
Dopamine 1 Receptor
16%
Dopamine Receptor D2
16%
Hamster Model
16%
Hypoactive Sexual Desire Disorder
100%
Melanocortin
16%
Melanocortin 4 Receptor
50%
Melanocortin Receptor
33%
Messenger RNA
50%
Preference
16%
Receptor
16%
Sexual Dysfunction
16%
Syrian Hamster
100%